Atossa Therapeutics (ATOS) EBITDA Margin Growth (3y) (2014 - 2015)
Powered by 
Analysis
Atossa Therapeutics (ATOS) EBITDA Margin Growth (3y) (2014 - 2015) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 842.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 214.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -963.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 2,139.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -1,031.00 |
| 10 | Atossa Therapeutics | 25.15 Mn | 25.15 Mn | - | - |